On August 7, 2020, the Personalized Medicine Coalition, Illumina, BCBS Association, and Concert Genetics released a new report that "compares real world health insurance claims for genomic testing" with coverage policies.
The report finds "wide variation and a lack of clarity in payer coverage."
The report's take home lessons are:
- Medically appropriate genomic testing is inconsistently utilized.
- Payer genomic policy vary considerably.
- Favorable coverage may not correlate with increased utilization.
- Inconsistent policies are barriers, but policies alone don't explain inconsistent access.
For some recent academic publications on similar topics, see: